Nasdaq - Delayed Quote USD

Delaware Ivy Science and Technology R (WSTRX)

53.39 +0.32 (+0.60%)
At close: October 25 at 8:01 PM EDT
Loading Chart for WSTRX
DELL
  • Previous Close 53.07
  • YTD Return 28.70%
  • Expense Ratio 1.41%
  • Category Technology
  • Last Cap Gain 48.00
  • Morningstar Rating
  • Morningstar Risk Rating Average
  • Sustainability Rating
  • Net Assets 5.97B
  • Beta (5Y Monthly) 1.30
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 29.00%
  • Last Dividend --
  • Inception Date Jul 3, 2000

The fund invests primarily in the equity securities of science and technology companies around the globe. Under normal circumstances, it invests at least 80% of its net assets in securities of science or technology companies. The fund also may invest in companies that utilize science and/or technology as an agent of change to significantly enhance their business opportunities. It may invest in securities issued by companies of any size, and may invest without limitation in foreign securities, including securities of issuers within emerging markets. The fund is non-diversified.

Delaware Funds by Macquarie

Fund Family

Technology

Fund Category

5.97B

Net Assets

2000-07-03

Inception Date

Performance Overview: WSTRX

View More

Trailing returns as of 10/25/2024. Category is Technology.

YTD Return

WSTRX
28.70%
Category
12.31%
?

1-Year Return

WSTRX
52.77%
Category
53.90%
?

3-Year Return

WSTRX
8.86%
Category
27.50%
?

5-Year Return

WSTRX
16.83%
Category
28.80%
?

People Also Watch

Holdings: WSTRX

View More

Top 10 Holdings (56.99% of Total Assets)

SymbolCompany% Assets
META
Meta Platforms, Inc. 9.19%
NVDA
NVIDIA Corporation 8.73%
MSFT
Microsoft Corporation 7.29%
STX
Seagate Technology Holdings plc 5.56%
AVGO
Broadcom Inc. 5.40%
ZBRA
Zebra Technologies Corporation 4.59%
AMZN
Amazon.com, Inc. 4.53%
AAPL
Apple Inc. 4.29%
ASML
ASML Holding N.V. 3.71%
TSM
Taiwan Semiconductor Manufacturing Company Limited 3.69%

Sector Weightings

Recent News: WSTRX

View More

Research Reports: WSTRX

View More

Top Mutual Funds